- TLDR Biotech
- Archive
- Page 13
The Latest Biotech & Pharma Updates
Biotech & Pharma Updates | July 16 - 17, 2024
Roche's obesity pill posts positive Ph1, J&J earnings stay positive despite looming IRA, NGM nabs $122M raise after going private, Sanofi doubles Hyderabad workforce, Actuate's $50M upcoming IPO, FDA launches rare disease innovation hub, and Roche's Genentech bails on Relay Therapeutics partnership
Biotech & Pharma Updates | July 15 - 16, 2024
Cardurion raises $260M for cardiac small molecules, CordenPharma invests nearly a billion in GLP-1 capacity expansion, Sionna gets hands on abandoned AbbVie CF asset, Vertex and Orum partner on new Casgevy conditioning regiment, ICER doesn't like Verona's COPD treatment price
Biotech & Pharma Updates | July 11 - 14, 2024
AbbVie's Rinvoq label expansion application, semaglutide correlates with lowered dementia risks, IDEAYA Biosciences raises over $300M through public offering, two health SPACS launch with a combined $400M, Spark Therapeutics layoffs, and Big Pharma & PBMs play drug price blame game
Biotech & Pharma Updates | July 10 - 11, 2024
Pfizer's one-daily obesity pill moves forward, Illumina competitor lands $277M Series D, Novo Nordisk once-weekly insulin injection rejected by FDA, Novartis to shutter San Diego R&D site, and FTC sues Pharmacy Benefit Managers over insulin prices
Biotech & Pharma Updates | July 2 - 4, 2024
Beacon Therapeutics raises $170M Series B, Pentixapharm acquires Glycotope's antibody discovery arm, J&J lands FDA and EMA approval for multi-drug resistant TB therapy, and CureVac sells its Covid-19/flu assets while also laying off 30% of their staff
